"Novartis to slash nearly 2,000 U.S. jobs"
ZURICH (Reuters) - Novartis AG is slashing nearly 2,000 jobs in the United States ahead of the patent loss of its top-selling blood pressure drug Diovan, the Swiss drugmaker said on Friday, just months after it said would scale back operations in Switzerland.